Lexicon Pharmaceuticals LXRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.1M+284% | $5.49M-61.3% | $14.18M-50.9% | $28.87M+2,187% | $1.26M-95.2% | ||
| $108K-46.3% | $201K+1,910% | $10K-69.7% | $33K+10.0% | $30K-91.4% | ||
| $20.99M+297% | $5.29M-62.7% | $14.17M-50.8% | $28.83M+2,240% | $1.23M-95.3% | ||
| 99.5%+3.1pp | 96.3%-3.6pp | 99.9%0.0pp | 99.9%+2.3pp | 97.6%-1.1pp | ||
| $12.76M+12.7% | $11.32M-39.7% | $18.76M+19.1% | $15.75M+2.9% | $15.3M-42.7% | ||
| $9.23M+5.4% | $8.76M+15.2% | $7.6M-18.7% | $9.35M-19.5% | $11.61M-64.0% | ||
| $22.1M+9.0% | $20.27M-23.1% | $26.37M+4.9% | $25.13M-6.7% | $26.94M-54.6% | ||
| -$996K+93.3% | -$14.78M-21.3% | -$12.19M-426% | $3.74M+115% | -$25.68M+21.6% | ||
| -4.7%+264pp | -269.1%-183pp | -85.9%-98.9pp | 12.9%+2,048pp | -2,034.8%-1,912pp | ||
| $1.48M-12.3% | $1.69M-4.1% | $1.76M-8.5% | $1.92M-35.3% | $2.97M-5.0% | ||
| $1.54M+20.5% | $1.28M-18.6% | $1.57M-14.2% | $1.83M-17.4% | $2.22M-21.6% | ||
| —— | —— | —— | —— | —— | ||
| -$1.04M+93.3% | -$15.53M-21.6% | -$12.77M-493% | $3.25M+113% | -$25.3M+25.1% | ||
| -4.9%+278pp | -282.7%-193pp | -90%-101pp | 11.3%+2,016pp | -2,004.4%-1,877pp | ||
| $0.00+100% | -$0.040.0% | -$0.04-500% | $0.01+114% | -$0.07+22.2% | ||
| -$886K+94.0% | -$14.66M-21.8% | -$12.04M-408% | $3.91M+115% | -$25.5M+21.8% | ||
| -4.2%+263pp | -266.9%-182pp | -84.9%-98.4pp | 13.6%+2,034pp | -2,020.8%-1,898pp | ||
| -$996K+93.3% | -$14.78M-21.3% | -$12.19M-426% | $3.74M+115% | -$25.68M+21.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lexicon Pharmaceuticals's revenue?
- Lexicon Pharmaceuticals (LXRX) generated $69.6M in revenue over the trailing twelve months, up 123.1% year over year.
- Is Lexicon Pharmaceuticals profitable?
- Lexicon Pharmaceuticals is not currently profitable: it reported a net loss of $26.1M over the trailing twelve months, a -37.5% net margin.
- What are Lexicon Pharmaceuticals's profit margins?
- Gross margin is 99.5% and operating margin is -34.8%, with a -37.5% net margin.
- What is Lexicon Pharmaceuticals's earnings per share?
- Lexicon Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.07.
- Where does Lexicon Pharmaceuticals's income statement data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
